IBC Life Sciences

Co-located Conference

Co-located with IBC's Single-Use Applications for Biopharmaceutical Manufacturing.
Registered attendees of IBC's Vaccine Production Summit can also attend the sessions of this co-located conference.

» View the agenda at a glance for both conferences

Special Discounted Hotel Rate

Special Discounted Hotel Rate Available Until May 24, 2010.
To book your room, call +1 858 552 1234 and mention that you are an IBC attendee at this event.

Keynote Presentations

Dennis M. Klinman, M.D., Ph.D., National Cancer Institute
Improving Interactions Between the FDA, Regulated Industry, and Academia

George A. Robertson, Ph.D., PATH
Using Next Generation Production Methods to Add Vaccine Production Capacity in Developing Countries

Matthew Stober, Ph.D., Novartis Vaccines & Diagnostics
The Remaking of a Biopharm Manufacturing Organization and its Impact on 2009 Production of H1N1 Vaccine

Pre-Conference Workshop

Implementing the New Process Validation Guidelines and New Technologies for Vaccine Production

IBC's Vaccines Production Summit 2010 provides a case study forum for the most cutting edge technologies, issues and approaches related to the process development and manufacturing of traditional and novel therapeutic vaccines.

2010 Meeting Highlights:

• An interactive pre-conference workshop helps you explore the impacts of new FDA process validation guidelines
• A keynote presentation from Dr. Dennis Klinman (former FDA Scientist of the Year) offers best practices for improving interactions between the FDA, industry and academia
• PATH explains how next generation vaccine production technologies are being deployed in developing countries to improve cost of goods and speed distribution
• Novartis details its conversion of the former Chiron manufacturing facility and how the resulting production line generated over 100 million doses of H1N1 vaccine during the 2009 flu season
• Learn about the state of the art (and state of the science) in expression systems, purification technology, scale-up, technology transfer and more!

The Most Cutting Edge Technologies, Issues & Approaches:

• Learn how to improve interactions between FDA, industry & academia
• Explore next generation production methods to improve capacity
• Refine your vaccines scale-up and technology transfer programs
• Find new production steps for innovative immunotherapeutics
• Hear case studies of novel purification approaches

The meeting includes discussion of novel technologies that can be applied to the production of traditional vaccines, and the novel approaches being applied to production of the new class of "therapeutic" vaccines now being developed for cancer, HIV/AIDS and other indications.

Topics to be Covered Include:

• Accelerating CMC Development for Vaccines
• Next Generation Expression Systems for Increased Yield and Quality
• Novel Vaccine Purification Methods
• Process Development for New Classes of Immunotherapies
• Process Development for Novel Adjuvants
• Production Issues for Conjugate Vaccines
• Single Use Systems for Vaccine Production (session shared with co-located Single Use)
• Vaccines Process Validation
• Scale-Up and Technology Transfer
• Vaccine Formulation, Stability and Delivery
• Analytical Characterization and Release Specifications

Co-Location with IBC'S Single-Use Applications for Biopharmaceuticals Manufacturing:
This year the conference is concurrent with IBC's Single-Use Applications for Biopharmaceuticals Manufacturing conference and you will profit from additional networking opportunities and a joint session on single use systems for vaccine production including integrating disposables into legacy vaccine production lines and implementation of disposable bioreactors.